Malaria is a global disease affecting a large portion of the world’s population. Although vaccines have recently become available, their efficacies are suboptimal. We generated virus-like particles (VLPs) that expressed either apical membrane antigen 1 (AMA1) or microneme-associated antigen (MIC) of Plasmodium berghei and compared their efficacy in BALB/c mice. We found that immune sera acquired from AMA1 VLP- or MIC VLP-immunized mice specifically interacted with the antigen of choice and the whole P. berghei lysate antigen, indicating that the antibodies were highly parasite-specific. Both VLP vaccines significantly enhanced germinal center B cell frequencies in the inguinal lymph nodes of mice compared with the control, but only the mice that received MIC VLPs showed significantly enhanced CD4+ T cell responses in the blood following P. berghei challenge infection. AMA1 and MIC VLPs significantly suppressed TNF-α and interleukin-10 production but had a negligible effect on interferon-γ. Both VLPs prevented excessive parasitemia buildup in immunized mice, although parasite burden reduction induced by MIC VLPs was slightly more effective than that induced by AMA1. Both VLPs were equally effective at preventing body weight loss. Our findings demonstrated that the MIC VLP was an effective inducer of protection against murine experimental malaria and should be the focus of further development.
Citations
Citations to this article as recorded by
Orally Dissolving Film-Based Influenza Vaccines Confer Superior Protection Compared to the Oral Administration of Inactivated Influenza Virus Keon-Woong Yoon, Jie Mao, Gi-Deok Eom, Su In Heo, Ki Back Chu, Mi Suk Lee, Fu-Shi Quan Vaccines.2025; 13(6): 600. CrossRef
Protective Efficacy Induced by Virus-like Particles Expressing Dense Granule Protein 5 of Toxoplasma gondii Su In Heo, Hae-Ji Kang, Jie Mao, Zhao-Shou Yang, Md Atique Ahmed, Fu-Shi Quan Vaccines.2025; 13(8): 787. CrossRef
Efficacy of Heterologous Vaccination Using Virus-Like Particles and Vaccinia Virus Containing MIC8 and AMA1 Proteins of Toxoplasma gondii Hae-Ji Kang, Fu-Shi Quan Vaccines.2025; 13(8): 862. CrossRef
Ivermectin Identified Using a High-Throughput Screening System Exhibits Anti-Clonorchis sinensis Activity in Rats Soon-Ok Lee, Hyeryon Lee, Ki Back Chu, Jianhua Li, Sung-Jong Hong, Sung Soo Kim, Joo Hwan No, Fu-Shi Quan Antibiotics.2025; 14(8): 837. CrossRef
Toxoplasma gondii infections are primarily diagnosed by serological assays, whereas molecular and fluorescence-based techniques are garnering attention for their high sensitivity in detecting these infections. Nevertheless, each detection method has its limitations. The toxoplasmosis detection capabilities of most of the currently available methods have not been evaluated under identical experimental conditions. This study aimed to assess the diagnostic potential of enzyme-linked immunosorbent assay (ELISA), real-time polymerase chain reaction (RT-PCR), immunohistochemistry (IHC), and immunofluorescence (IF) in BALB/c mice experimentally infected with various doses of T. gondii ME49. The detection of toxoplasmosis from sera and brain tissues was markedly enhanced in mice subjected to high infection doses (200 and 300 cysts) compared to those subjected to lower doses (10 and 50 cysts) for all the detection methods. Additionally, increased B1 gene expression levels and cyst sizes were observed in the brain tissues of the mice. Importantly, IHC, IF, and ELISA, but not RT-PCR, successfully detected T. gondii infections at the lowest infection dose (10 cysts) in the brain. These findings may prove beneficial while designing experimental methodologies for detecting T. gondii infections in mice.
Citations
Citations to this article as recorded by
Spatiotemporal Diffusion, Colonization, and Antibody Responses in Susceptible C57BL/6J Mice Orally Infected with Toxoplasma gondii Cysts Zhao Li, Qi-Shuai Liu, Jun-Jie Hu, Cai-Qin Deng, Tao Li, Wen-Bin Zheng, Xing-Quan Zhu, Feng-Cai Zou Veterinary Sciences.2025; 12(3): 212. CrossRef
Ivermectin Identified Using a High-Throughput Screening System Exhibits Anti-Clonorchis sinensis Activity in Rats Soon-Ok Lee, Hyeryon Lee, Ki Back Chu, Jianhua Li, Sung-Jong Hong, Sung Soo Kim, Joo Hwan No, Fu-Shi Quan Antibiotics.2025; 14(8): 837. CrossRef
Recombinant vaccinia virus expressing MIC8, AMA1, or RON4 induce protection against Toxoplasma gondii ME49 strain infection Hae-Ji Kang, Fu-Shi Quan Acta Tropica.2025; 270: 107812. CrossRef
Protective Efficacy Induced by Virus-like Particles Expressing Dense Granule Protein 5 of Toxoplasma gondii Su In Heo, Hae-Ji Kang, Jie Mao, Zhao-Shou Yang, Md Atique Ahmed, Fu-Shi Quan Vaccines.2025; 13(8): 787. CrossRef
Vaccinia virus expressing MIC8 and AMA1 provides protection against Toxoplasma gondii ME49 infection Hae-Ji Kang, Yan Jin, Zhao-Shou Yang, Md Atique Ahmed, Fu-Shi Quan Parasites, Hosts and Diseases.2025; 63(4): 340. CrossRef
Toxoplasma gondii ME49 infections are typically diagnosed by serological tests. However, serological diagnosis of RH strain-induced toxoplasmosis remains unknown. In order to develop seradiagnosis of above 2 kinds of infections, we generated recombinant virus-like particles (VLPs) displaying the T. gondii rhoptry protein 4 (ROP4) and evaluated their potential in T. gondii ME49 or RH strain infection diagnostics. Mice were orally infected with either the tachyzoites of T. gondii (RH) or cysts of T. gondii (ME49) at various dosages, and sera were collected at regular intervals. ELISA-based serological tests were performed to assess IgG, IgM, and IgA antibody responses against ROP4 VLP antigen and tissue lysate antigen (TLA). Compared to TLA, IgG, IgM, and IgA levels to ROP4 VLP antigen were significantly higher in the sera of T. gondii RH-infected mice 1 and 2 week post-infection (PI). T. gondii-specific IgG antibody was detected at 1, 2, 4, and 8 week PI in the T. gondii ME49-infected mice with infection dose-dependent manner. These results indicated that the ROP4 VLP antigen was highly sensitive antigens detecting T. gondii RH and ME49 antibodies at an early stage.
Citations
Citations to this article as recorded by
IgM Antibody Detection as a Diagnostic Marker for Acute Toxoplasmosis: Current Status of Studies and Main Limitations Karolina Sołowińska, Lucyna Holec-Gąsior Antibodies.2025; 14(2): 44. CrossRef
Could metformin modulate the outcome of chronic murine toxoplasmosis? Maha Mohamed Gomaa, Samar Nabil El Achy, Nehal Nassef Hezema Acta Tropica.2024; 258: 107339. CrossRef
Trend in serological and molecular diagnostic methods for Toxoplasma gondii infection Min-ju Kim, Soeun J. Park, Hyunwoo Park European Journal of Medical Research.2024;[Epub] CrossRef
Recombinant AMA1 Virus-like Particle Antigen for Serodiagnosis of Toxoplasma gondii Infection Min-Ju Kim, Ki-Back Chu, Jie Mao, Hae-Ji Kang, Gi-Deok Eom, Keon-Woong Yoon, Su-Hwa Lee, Eun-Kyung Moon, Young-Ha Lee, Fu-Shi Quan Biomedicines.2022; 10(11): 2812. CrossRef
Toxoplasmagondii can infect humans worldwide, causing serious diseases in pregnant women and immunocompromised individuals. T. gondii rhoptry protein 13 (ROP13) is known as one of the key proteins involved in host cell invasion. In this study, we generated virus-like particles (VLPs) vaccine expressing T. gondii rhoptry ROP13 and investigated VLPs vaccine efficacy in mice. Mice immunized with ROP13 VLPs vaccine elicited significantly higher levels of T. gondii-specific IgG, IgG1, IgG2a, and IgA antibody responses following boost immunization and challenge infection, whereas antibody inductions were insignificant upon prime immunization. Differing immunization routes resulted in differing antibody induction, as intranasal immunization (IN) induced greater antibody responses than intramuscular immunization (IM) after boost and challenge infection. IN immunization induced significantly higher levels of IgG and IgA antibody responses from feces, antibody-secreting cells (ASCs), CD4+ T, CD8+ T cells and germinal center B cell responses in the spleen compared to IM immunization. Compared to IM immunization, IN immunization resulted in significantly reduced cyst counts in the brain as well as lesser body weight loss, which contributed to better protection. All of the mice immunized through either route survived, whereas all na?ve control mice perished. These results indicate that the ROP13 VLPs vaccine could be a potential vaccine candidate against T. gondii infection.
Citations
Citations to this article as recorded by
A state-of-the-art methodology for high-throughput in silico vaccine discovery against protozoan parasites and exemplified with discovered candidates for Toxoplasma gondii Stephen J. Goodswen, Paul J. Kennedy, John T. Ellis Scientific Reports.2023;[Epub] CrossRef
Recent progress in vaccine development targeting pre-clinical human toxoplasmosis Ki-Back Chu, Fu-Shi Quan Parasites, Hosts and Diseases.2023; 61(3): 231. CrossRef
Protective immunity induced by CpG ODN‐adjuvanted virus‐like particles containing Toxoplasma gondii proteins Hae‐Ji Kang, Ki‐Back Chu, Min‐Ju Kim, Su‐Hwa Lee, Hyunwoo Park, Hui Jin, Eun‐Kyung Moon, Fu‐Shi Quan Parasite Immunology.2021;[Epub] CrossRef
Protective Immunity Against Neospora caninum Infection Induced by 14-3-3 Protein in Mice Shan Li, Nan Zhang, Shaoxiong Liu, Jianhua Li, Li Liu, Xiaocen Wang, Xin Li, Pengtao Gong, Xichen Zhang Frontiers in Veterinary Science.2021;[Epub] CrossRef
Toxoplasma gondii virus‐like particle vaccination alleviates inflammatory response in the brain upon T gondii infection Hae‐Ji Kang, Ki‐Back Chu, Su‐Hwa Lee, Min‐Ju Kim, Hyunwoo Park, Hui Jin, Eun‐Kyung Moon, Fu‐Shi Quan Parasite Immunology.2020;[Epub] CrossRef
Evaluation of CpG-ODN-Adjuvanted Toxoplasma gondii Virus-Like Particle Vaccine upon One, Two, and Three Immunizations Hae-Ji Kang, Ki-Back Chu, Min-Ju Kim, Hyunwoo Park, Hui Jin, Su-Hwa Lee, Eun-Kyung Moon, Fu-Shi Quan Pharmaceutics.2020; 12(10): 989. CrossRef
First
Prev
